Nickerson Joan's most recent trade in Verve Therapeutics Inc was a trade of 9,315 Common Stock done . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 9,315 | 20,197 | - | - | Common Stock | |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 6,000 | 18,000 | - | - | Restricted Stock Units | |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 3,315 | 6,630 | - | - | Restricted Stock Unuits | |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 4.15 per share. | 01 Apr 2025 | 2,777 | 17,420 | - | 4.2 | 11,525 | Common Stock |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2025 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,315 | 9,945 | - | - | Restricted Stock Units | |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,315 | 10,173 | - | - | Common Stock | |
| Verve Therapeutics Inc | Joan Nickerson | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 8.24 per share. | 01 Apr 2024 | 1,514 | 8,659 | - | 8.2 | 12,475 | Common Stock |
| Verve Therapeutics Inc | Nickerson Joan | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Nickerson Joan | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 24,000 | 24,000 | - | - | Restricted Stock Units |